Company
Headquarters: New Taipei City, Taiwan
CEO: Gene Chen
TW$2.31 Billion
TWD as of Jan. 1, 2025
US$70.5 Million
| Company | Market Cap (USD) |
|---|---|
| Thermo Fisher Scientific | $219.88 B |
| Danaher | $177.43 B |
| Siemens Healthineers AG | $59.19 B |
| Agilent Technologies, Inc. | $43.57 B |
| Lonza Group Ltd | $41.66 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
DIVA Laboratories, Ltd. manufactures and sells display solutions worldwide. It provides endo/surgical displays, which provide static and dynamic images for hybrid and integrated ORs, and control room applications; color and mono displays for radiology and medical imaging; touch displays; and displays to ODM and OEM customers. The company is headquartered in New Taipei City, Taiwan.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
DIVA Laboratories Ltd has the following listings and related stock indices.
Stock: TWSE: 4153 wb_incandescent